臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
Profile: 分生二線藥物報告-Observation Moleculex
status:Final
category:Laboratory
code:分生二線藥物報告
subject:Patient/example
分生二線藥物報告日期(effective):2026-02-18
送驗單位(performer):Organization/hosp
component
code:FLQ
value:無法判定
component
code:KM
value:無法判定
component
code:AMK
value:無法判定
component
code:CM
value:無法判定
component
code:ETH
value:無法判定
component
code:PZA
value:無法判定